250 related articles for article (PubMed ID: 25601323)
1. How are we using systemic drugs to treat psoriasis in children? An insight into current clinical U.K. practice.
Burden-Teh E; Lam ML; Taibjee SM; Taylor A; Webster S; Dolman S; Jury C; Caruana D; Darne S; Carmichael A; Natarajan S; McPherson T; Moore A; Katugampola R; Kalavala M; Al-Ismail D; Richards L; Jones V; Batul Syed S; Glover M; Hughes J; Anderson E; Hughes B; Helbling I; Murphy R
Br J Dermatol; 2015 Aug; 173(2):614-8. PubMed ID: 25601323
[No Abstract] [Full Text] [Related]
2. [Systemic therapy of psoriasis].
Altmeyer P; Nüchel C
Dtsch Med Wochenschr; 1996 Dec; 121(51-52):1605-7. PubMed ID: 9011488
[No Abstract] [Full Text] [Related]
3. Systemic treatments in childhood psoriasis: a French multicentre study on 154 children.
Charbit L; Mahé E; Phan A; Chiaverini C; Boralevi F; Bourrat E; Lasek A; Maruani A; Aubin F; Droitcourt C; Barbarot S; Mallet S; Mazereeuw-Hautier J; Begon E; Abasq C; Plantin P; Souillet AL; Hadj-Rabia S; Bursztejn AC;
Br J Dermatol; 2016 May; 174(5):1118-21. PubMed ID: 26617180
[No Abstract] [Full Text] [Related]
4. Failure of combination therapy with acitretin and cyclosporin A in 3 patients with erythrodermic psoriasis.
Kuijpers AL; van Dooren-Greebe JV; van de Kerkhof PC
Dermatology; 1997; 194(1):88-90. PubMed ID: 9031805
[No Abstract] [Full Text] [Related]
5. Current and future oral systemic therapies for psoriasis.
Kelly JB; Foley P; Strober BE
Dermatol Clin; 2015 Jan; 33(1):91-109. PubMed ID: 25412786
[TBL] [Abstract][Full Text] [Related]
6. Methotrexate or fumarates: which is the best oral treatment for psoriasis?
Barker JN
Br J Dermatol; 2011 Apr; 164(4):695. PubMed ID: 21457199
[No Abstract] [Full Text] [Related]
7. European S3-Guidelines on the systemic treatment of psoriasis vulgaris--Update 2015--Short version--EDF in cooperation with EADV and IPC.
Nast A; Gisondi P; Ormerod AD; Saiag P; Smith C; Spuls PI; Arenberger P; Bachelez H; Barker J; Dauden E; de Jong EM; Feist E; Jacobs A; Jobling R; Kemény L; Maccarone M; Mrowietz U; Papp KA; Paul C; Reich K; Rosumeck S; Talme T; Thio HB; van de Kerkhof P; Werner RN; Yawalkar N
J Eur Acad Dermatol Venereol; 2015 Dec; 29(12):2277-94. PubMed ID: 26481193
[No Abstract] [Full Text] [Related]
8. Psoriasis is a systemic disease with multiple cardiovascular and metabolic comorbidities.
Ryan C; Kirby B
Dermatol Clin; 2015 Jan; 33(1):41-55. PubMed ID: 25412782
[TBL] [Abstract][Full Text] [Related]
9. A simple intervention to improve safety in methotrexate prescribing.
Birnie AJ; Littlewood SM
Australas J Dermatol; 2007 May; 48(2):134. PubMed ID: 17535208
[No Abstract] [Full Text] [Related]
10. Treatment of psoriasis. Part 2. Systemic therapies.
Lebwohl M; Ali S
J Am Acad Dermatol; 2001 Nov; 45(5):649-61; quiz 662-4. PubMed ID: 11606913
[TBL] [Abstract][Full Text] [Related]
11. Systemic antipsoriatic combination therapy with fumaric acid esters for plaque-type psoriasis: report on 17 cases.
Wilsmann-Theis D; Frambach Y; Philipp S; Weyergraf AJ; Jacobi A; Mössner R; Gerdes S
Dermatology; 2015; 230(2):119-27. PubMed ID: 25661583
[TBL] [Abstract][Full Text] [Related]
12. Vitamin D and systemic therapy.
van de Kerkhof P
Cutis; 2002 Nov; 70(5 Suppl):16-20. PubMed ID: 12467335
[TBL] [Abstract][Full Text] [Related]
13. Biologic and Conventional Systemic Therapies Show Similar Safety and Efficacy in Elderly and Adult Patients With Moderate to Severe Psoriasis.
Garber C; Plotnikova N; Au SC; Sorensen EP; Gottlieb A
J Drugs Dermatol; 2015 Aug; 14(8):846-52. PubMed ID: 26267729
[TBL] [Abstract][Full Text] [Related]
14. Persistence and effectiveness of nonbiologic systemic therapies for moderate-to-severe psoriasis in adults: a systematic review.
Mason KJ; Williams S; Yiu ZZN; McElhone K; Ashcroft DM; Kleyn CE; Jabbar-Lopez ZK; Owen CM; Reynolds NJ; Smith CH; Wilson N; Warren RB; Griffiths CEM
Br J Dermatol; 2019 Aug; 181(2):256-264. PubMed ID: 30628069
[TBL] [Abstract][Full Text] [Related]
15. Essential Truths for the Care and Management of Moderate-to-Severe Psoriasis.
Blauvelt A; Armstrong AW; Krueger GG
J Drugs Dermatol; 2015 Aug; 14(8):805-12. PubMed ID: 26267724
[TBL] [Abstract][Full Text] [Related]
16. Treatment patterns with systemic antipsoriatic agents in childhood psoriasis: an Italian database analysis.
DI Lernia V; Neri I; Calzavara Pinton P; DI Nuzzo S; Stingeni L; Guarneri C; Belloni Fortina A; Bonamonte D; Cambiaghi S; Lasagni C; Panzone M; Corazza M; Offidani A; Gisondi P
G Ital Dermatol Venereol; 2017 Aug; 152(4):327-332. PubMed ID: 26761766
[TBL] [Abstract][Full Text] [Related]
17. Management of patients with psoriasis.
Croney S
Br J Nurs; 2017 Mar; 26(5):260-262. PubMed ID: 28328264
[TBL] [Abstract][Full Text] [Related]
18. Current systemic therapies for psoriasis: where are we now?
Yamauchi PS; Rizk D; Kormeili T; Patnaik R; Lowe NJ
J Am Acad Dermatol; 2003 Aug; 49(2 Suppl):S66-77. PubMed ID: 12894129
[TBL] [Abstract][Full Text] [Related]
19. Sequential therapy using cyclosporine and acitretin for treatment of total body psoriasis.
Short MW; Vaughan TK
Cutis; 2004 Sep; 74(3):185-8. PubMed ID: 15499760
[TBL] [Abstract][Full Text] [Related]
20. Conventional systemic agents for psoriasis. A systematic review.
Strober BE; Siu K; Menon K
J Rheumatol; 2006 Jul; 33(7):1442-6. PubMed ID: 16724368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
